Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2513.88 (Glytoucan)

Id:ab5f3261-5603-5b2f-aba5-d25d7d7ff6ee

Glytoucan:G10540LB

Results found

Linked to

	Label	Description
	2513.88 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000004 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2513.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G29130SY-GLYCOSEQ00121619 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2513.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G56095ZZ-GLYCOSEQ00129397 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2513.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G53795OV-GLYCOSEQ00025681 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2513.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G56265BA-GLYCOSEQ00011031 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2513.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G00320ZP-GLYCOSEQ00164096 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2513.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G99518NJ-GLYCOSEQ00157735 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2513.88 has motif Type 2 LN Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2513.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G39377JQ-GLYCOSEQ00002251 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2513.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G72179WW-GLYCOSEQ00020203 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2513.88 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000004 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2513.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G29130SY-GLYCOSEQ00121619 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2513.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G56095ZZ-GLYCOSEQ00129397 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2513.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G53795OV-GLYCOSEQ00025681 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2513.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G56265BA-GLYCOSEQ00011031 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2513.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G00320ZP-GLYCOSEQ00164096 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2513.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G99518NJ-GLYCOSEQ00157735 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2513.88 has motif Type 2 LN

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2513.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G39377JQ-GLYCOSEQ00002251 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2513.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G72179WW-GLYCOSEQ00020203 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.